(Q73049405)

English

Continuous inhibition of excessive polyol pathway flux in peripheral nerves by aldose reductase inhibitor fidarestat leads to improvement of diabetic neuropathy

scientific article published on 01 May 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509874%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Continuous inhibition of excessive polyol pathway flux in peripheral nerves by aldose reductase inhibitor fidarestat leads to improvement of diabetic neuropathy (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509874%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

diabetic neuropathy

1 reference

based on heuristic

inferred from title

author name string

Mizuno K

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509874%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Kato N

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509874%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Makino M

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509874%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Suzuki T

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509874%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Shindo M

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509874%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 May 1999

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509874%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Journal of Diabetes and its Complications

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509874%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509874%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509874%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

141-150

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509874%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

The pharmacology of aldose reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperglycemia, Polyol Metabolism, and Complications of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Degenerated intramural pericytes (‘ghost cells’) in the retinal capillaries of diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of urinary albumin excretion in 6 month streptozocin-diabetic rats with the aldose reductase inhibitor tolrestat

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Aldose reductase inhibitors and diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetic Neuropathy—New Concepts of Its Etiology

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Aldose reductase inhibition improves nerve conduction velocity in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Aldose reductase in the etiology of diabetic complications. 3. Neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Complications: neuropathy, pathogenetic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Withdrawal of the aldose reductase inhibitor tolrestat in patients with diabetic neuropathy: effect on nerve function. The Tolrestat Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Peripheral nerves in early experimental diabetes: expansion of the endoneurial space as a cause of increased water content

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Inositol changes in nerve and lens of galactose fed rats

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A sodium-pump defect in diabetic peripheral nerve corrected by sorbinil administration: relationship to myo-inositol metabolism and nerve conduction slowing

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Glycation products and the pathogenesis of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolic and vascular factors in the pathogenesis of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Sorbitol Pathway: Presence in Nerve and Cord with Substrate Accumulation in Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Free sugars in alloxan diabetic rat nerve

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The sorbitol pathway. Enzyme localization and content in normal and diabetic nerve and cord.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Relation of Na+, K(+)-ATPase to delayed motor nerve conduction velocity: effect of aldose reductase inhibitor, ADN-138, on Na+, K(+)-ATPase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of polyol pathway in nonenzymatic glycation

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute str

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical investigation of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy in Japan: multicenter study. Diabetic Neuropathy Study Group in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Serial changes of sensory nerve conduction velocity and minimal F-wave latency in streptozotocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Serial in vivo determinations of nerve conduction velocity in rat tails. Physiological and pathological changes.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Electrophysiological follow up of experimental allergic neuritis mediated by a permanent T cell line in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of a novel aldose reductase inhibitor, FR74366, and its effects on diabetic cataract and neuropathy in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Amelioration of neurovascular deficits in diabetic rats by a novel aldose reductase inhibitor, GP-1447: minor contribution of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetic neuropathy in sucrose-fed Otsuka Long-Evans Tokushima fatty rats: effect of an aldose reductase inhibitor, TAT.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of long-term treatment with a new aldose reductase inhibitor, (2S,4S)-6-fluoro-2',5'-dioxospiro-[chroman-4,4'-imidazolidine]-2-carbox amide (SNK-860), on peripheral neuropathy in streptozotocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A combination of the aldose reductase inhibitor, statil, and the prostaglandin E1 analogue, OP1206.alpha CD, completely improves sciatic motor nerve conduction velocity in streptozocin-induced chronically diabetic rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased resistance to hypoxic conduction block in sciatic nerves of diabetic rats: effects of extracellular glucose concentration and of aldose reductase inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo activities of aldose reductase inhibitors having a 1-(arylsulfonyl)hydantoin structure

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The correlation between sensory nerve conduction velocities and three metabolic indices in rats treated with streptozotocin

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Sensory and motor nerve conduction velocities and the latency of the H reflex during growth of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Amelioration by the Ca2+ antagonist, nimodipine of an existing neuropathy in the streptozotocin-induced, diabetic rat

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Diminished ouabain-sensitive, sodium-potassium ATPase activity in sciatic nerves of rats with streptozotocin-induced diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuropathy-functional abnormalities in the BB rat

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Reversible and irreversible nodal dysfunction in diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

F-wave latency, the most sensitive nerve conduction parameter in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical value of F-wave studies

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of a novel aldose reductase inhibitor, TAT, and its effects on streptozotocin-induced diabetic neuropathy in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of SG-210, a novel aldose reductase inhibitor, on impaired polyol pathway in rats received diabetic manipulations

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of sorbitol accumulation and myo-inositol depletion in paranodal swelling of large myelinated nerve fibers in the insulin-deficient spontaneously diabetic bio-breeding rat. Reversal by insulin replacement, an aldose reductase inhibitor, and myo

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Overt diabetic neuropathy: repair of axo-glial dysjunction and axonal atrophy by aldose reductase inhibition and its correlation to improvement in nerve conduction velocity

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical studies with an aldose reductase inhibitor in the autonomic and somatic neuropathies of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1056-8727(99)00038-0

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509874%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509874%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73049405&oldid=2004890980"